Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


An Electrophysiological Examination of CB1 and NMDA Receptors in Humans


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04199468

Organisation Name: Yale University

Overal Status: Recruiting

Start Date: September 24, 2019

Last Update: August 4, 2020

Lead Sponsor: Yale University

Brief Summary: The aim of the research protocol is to evaluate cannabinoid-glutamate interactions in humans. As part of this aim the investigators will assess the safety and tolerability of the combination of NMDA antagonist, ketamine, and the cannabinoid, delta-9-tetrahydrocannabinol (THC), in healthy adult subjects, and characterize the interactive effects of ketamine and THC on various electrophysiological (EEG), cognitive, and behavioral outcomes.

Conditions:
  • Cannabis
  • Ketamine


Total execution time in seconds: 0.36702489852905